Welcome : Guest

Aegerion Pharmaceuticals, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Aegerion Pharmaceuticals, Inc., which is principally involved in Biopharmaceuticals Business. Illustrated with 11 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-63657
Price: $550
Company Type: Public
Pages: 14
Date: November 2016
Market Data Tables: 11

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Aegerion Pharmaceuticals, Inc.’s Sales by Product Segment Worldwide (2015) in Percentage for Lomitapide, and Metreleptin......3
Table 2: Aegerion Pharmaceuticals, Inc.’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for USA, Brazil, and Others......4
Lipid-Lowering Drugs......6
Table 3: Lipid-Lowering Drug Market by Product Category China (2015) - Percentage Share Breakdown by Value for Statins, Xuezhikang, and Other Products......6
Table 4: Cholesterol Prescriptions Market by Product in the US (2015) - Percentage Share Breakdown by Volume for Fibrates, Statins, and Others......7
Cardiology Therapeutics......8
Table 5: Cardiovascular Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......8
Table 6: Cardiology Market by Category in the US (2015) - Percentage Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Anti-Arrhythmics, ARB's, Beta Blockers, Calcium Blockers, Cholesterol, Digitalis, Diuretics, Vasodilators, and Others......9
Table 7: Cardiology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cardiac Rhythm Management & Congestive Heart Failure Devices, Cardiac Surgery, and Interventional Cardiology......10
Cardiology Therapeutics......11
Table 8: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......11
Table 9: Aegerion Pharmaceuticals Inc.’s Lomitapide for Adult HoFH (Homozygous Familial Hypercholesterolemia) by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for European Union, Japan and United States......12
Table 10: Aegerion Pharmaceuticals Inc.’s Lomitapide for Pediatric HoFH (Homozygous Familial Hypercholesterolemia) by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for European Union, Japan and United States......13
Table 11: Aegerion Pharmaceuticals, Inc.’s Sales by Geographic Region Worldwide (2013-2014) in Percentage for United States and Others......14